Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H14F3N3O2S |
Molecular Weight | 393.383 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(=O)(=O)C1=CC=C(C=C1)C2=CC(C3=CC=C(N=C3)C(F)(F)F)=C(N)N=C2
InChI
InChIKey=RTJQABCNNLMCJF-UHFFFAOYSA-N
InChI=1S/C18H14F3N3O2S/c1-27(25,26)14-5-2-11(3-6-14)13-8-15(17(22)24-10-13)12-4-7-16(23-9-12)18(19,20)21/h2-10H,1H3,(H2,22,24)
Molecular Formula | C18H14F3N3O2S |
Molecular Weight | 393.383 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential. | 2012 Apr 12 |
|
Synthesis of 4-aminoquinoline-pyrimidine hybrids as potent antimalarials and their mode of action studies. | 2013 Aug |
|
Cell-based medicinal chemistry optimization of high throughput screening hits for orally active antimalarials. Part 2: hits from SoftFocus kinase and other libraries. | 2013 Oct 24 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:31:39 GMT 2023
by
admin
on
Sat Dec 16 18:31:39 GMT 2023
|
Record UNII |
0Z5T00JJ10
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
0Z5T00JJ10
Created by
admin on Sat Dec 16 18:31:40 GMT 2023 , Edited by admin on Sat Dec 16 18:31:40 GMT 2023
|
PRIMARY | |||
|
53311393
Created by
admin on Sat Dec 16 18:31:40 GMT 2023 , Edited by admin on Sat Dec 16 18:31:40 GMT 2023
|
PRIMARY | |||
|
1314883-11-8
Created by
admin on Sat Dec 16 18:31:40 GMT 2023 , Edited by admin on Sat Dec 16 18:31:40 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR | |||
|
TARGET ORGANISM->INHIBITOR |
Whole-cell blood stage activity of UCT943 against a panel of resistant P. falciparum strains to determine potential for cross-resistance compared with MMV048, chloroquine (CQ) and artesunate (AS)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |